Riverview Capital Advisers’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-5,170
| Closed | -$534K | – | 84 |
|
|
2023
Q3 | $534K | Sell |
5,170
-737
| -12% | -$76.1K | 0.24% | 63 |
|
|
2023
Q2 | $718K | Sell |
5,907
-4,143
| -41% | -$503K | 0.32% | 58 |
|
|
2023
Q1 | $1.54M | Buy |
10,050
+50
| +0.5% | +$7.68K | 0.66% | 35 |
|
|
2022
Q4 | $1.8M | Sell |
10,000
-50
| -0.5% | -$8.98K | 0.96% | 27 |
|
|
2022
Q3 | $1.19M | Buy |
10,050
+50
| +0.5% | +$5.91K | 0.75% | 38 |
|
|
2022
Q2 | $1.43M | Hold |
10,000
| – | – | 0.79% | 36 |
|
|
2022
Q1 | $1.72M | Sell |
10,000
-50
| -0.5% | -$8.61K | 0.79% | 35 |
|
|
2021
Q4 | $2.55M | Buy |
+10,050
| New | +$2.55M | 1.14% | 27 |
|